Kubota Pharmaceutical Holdings Co (TSE:4596) EPS (Basic): 円-5.80 (TTM As of Mar. 2026)


TSE:4596 Kubota Pharmaceutical Holdings Co Ltd TSE:4596
46 GF Score
Price 円56.00
GF Value 円39.85
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Kubota Pharmaceutical Holdings Co EPS (Basic)?

Kubota Pharmaceutical Holdings Co TSE:4596 -1.75% 46 EPS (Basic) is 円-5.80 as of Mar. 2026. GuruFocus rates TSE:4596 with a GF Score™ of 46/100 and a GF Value™ of 円39.85 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Kubota Pharmaceutical Holdings Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was 円-2.58. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was 円-5.80.

Kubota Pharmaceutical Holdings Co's EPS (Diluted) for the three months ended in Mar. 2026 was 円-2.58. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円-5.80.

Kubota Pharmaceutical Holdings Co's EPS without NRI for the three months ended in Mar. 2026 was 円-2.58. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -5.80.

During the past 3 years, the average EPS without NRI Growth Rate was 36.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 28.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Kubota Pharmaceutical Holdings Co's highest 3-Year average EPS without NRI Growth Rate was 36.30% per year. The lowest was 9.80% per year. And the median was 17.60% per year.

Kubota Pharmaceutical Holdings Co  (TSE:4596) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Kubota Pharmaceutical Holdings Co EPS (Basic) Related Terms

Kubota Pharmaceutical Holdings Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Kubota Pharmaceutical Holdings Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kubota Pharmaceutical Holdings Co EPS (Basic) Chart

Kubota Pharmaceutical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -57.46 -40.92 -26.79 -23.65 -10.59

Kubota Pharmaceutical Holdings Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -4.49 -3.22 0.00 -2.58
TSE:4596
46GF Score
Kubota Pharmaceutical Holdings Co Ltd TSE:4596
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kubota Pharmaceutical Holdings Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Kubota Pharmaceutical Holdings Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-676.253-0)/63.853
=-10.59

Kubota Pharmaceutical Holdings Co's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-312.126-0)/121.210
=-2.58

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-5.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of 円-5.80 mean?
Kubota Pharmaceutical Holdings Co (TSE:4596) has a EPS (Basic) of 円-5.80 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Kubota Pharmaceutical Holdings Co and its competitors.
Is Kubota Pharmaceutical Holdings Co's EPS (Basic) too high?
Kubota Pharmaceutical Holdings Co's current EPS (Basic) is 円-5.80. Overall, Kubota Pharmaceutical Holdings Co has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kubota Pharmaceutical Holdings Co's EPS (Basic) compare to VRTX and REGN?
Kubota Pharmaceutical Holdings Co's EPS (Basic) of 円-5.80 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. Kubota Pharmaceutical Holdings Co's current EPS (Basic) is 円-5.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kubota Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co (TSE:4596) is currently considered Significantly Overvalued. The stock's GF Value™ is 円39.85, compared to a current price of 円56.00 — trading 40.5% above its estimated fair value. The current EPS (Basic) is 円-5.80. Kubota Pharmaceutical Holdings Co's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Kubota Pharmaceutical Holdings Co (TSE:4596), the current EPS (Basic) is 円-5.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?

Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued. The current stock price of 円56.00 is trading 40.5% above its estimated GF Value™ of 円39.85. GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.

Key valuation signals for TSE:4596:

  • EPS (Basic): 円-5.80
  • GF Value™: 円39.85 vs. price of 円56.00 (40.5% above fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kubota Pharmaceutical Holdings Co Business Description

Address 1-15-37 Minami-Aoyama, Minato-ku, Tokyo, JPN, 107-0062
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
46GF Score

Get the complete analysis for TSE:4596

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円56.00
Price
円39.85
GF Value